COVID-19 outcomes in giant cell arteritis and polymyalgia rheumatica versus rheumatoid arthritis: A national, multicenter, cohort study

Journal of Autoimmunity(2022)

Cited 5|Views6
No score
Abstract
•GCA/PMR compared to RA patients have more frequently severe COVID-19 and higher mortality rate.•GCA/PMR worse COVID-19 outcomes are mostly due to known risk factors for the general population.•Risk stratification in pandemic should continue to prioritize patients with GCA/PMR.
More
Translated text
Key words
Giant cell arteritis,Polymyalgia rheumatica,Rheumatoid arthritis,COVID-19,SARS-CoV-2
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined